Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...

Wall Street saw a mixed week, with the benchmark S&P 500 Index adding a marginal 0.08%, the NASDAQ Composite Index ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Eli Lilly is poised to become the first $1 trillion pharmaceutical company, driven by explosive growth in its weight-loss ...

Starting April 1, 2026, Medicare will begin covering Lilly’s leading weight loss drug, Zepbound, along with Mounjaro, at $245—a 55% discount from current net prices, according to Leerink Partners.

Eli Lilly upgraded on coverage expansion for obesity drugs Leerink Partners upgraded Eli Lilly (LLY) to Outperform from Market Perform, arguing that its recent pricing deal with the Trump ...

Earnings Justify Rally?. Short Trade IdeaEnter your short position between $864.35 (the lower band of its horizontal resistance zone) and $915.22 (the lower band of its horizontal resistance zone).Mar ...

HSBC analyst Rajesh Kumar removed his reduce recommendation and upgraded S&P 500 component company Eli Lilly (NYSE: LLY) stock to hold with a $700 price target today. “Orforglipron’s ATTAIN-2 Phase 3 ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

Microsoft Corporation, Eli Lilly and Company, Oracle Corporation, Compagnie Financiere Richemont SA. Read 's Market Analysis on Investing.com ZA.